Effect of KRN4884 on lipid metabolism in hyperlipidemic rats

General Pharmacology

Volumn 30, Issue 2, 1998, Pages 233-237

  Yokoyama, Takashi ^a   Izumi, Hideakira ^a   Endoh, Megumi ^a   Ogawa, Nobuyuki ^a   Izawa, Toshio ^a   Okada, Yuji ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

KRN4884; Lipid metabolism; Potassium channel opener; Triglyceride

Indexed keywords

5 AMINO N [2 (2 CHLOROPHENYL)ETHYL] N' CYANO 3 PYRIDINECARBOXAMIDINE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHYLOMICRON; CLOFIBRATE; POTASSIUM CHANNEL STIMULATING AGENT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; DRUG EFFECT; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; DIETARY FATS; HYPERLIPIDEMIAS; LIPIDS; POTASSIUM CHANNELS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER;

EID: 0032008148     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00093-1     Document Type: Article

References (19)

1. Ashcroft S. J. H. and Ashcroft F. M. (1990) Properties and function of ATP-sensitive K-channels. Cell. Signaling 2, 197-214.
2. Austin M. A. (1991) Plasma triglyceride and coronary heart disease. Arterioscler. Thromb. 11, 2-14.
3. Fujioka S., Matsuzawa Y., Tokunaga K. and Tarui S. (1987) Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36, 54-59.
4. Hatch F. T. and Lee R. S. (1968) Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6, 1-68.
5. Izumi H., Jinno Y., Kaneta S., Tanaka Y., Okada Y., Izawa T. and Ogawa N. (1995) Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim nilvadipine, and nifedipine. J. Cardiovasc. Pharmac. 26, 189-197.
6. Kaplan N. M. (1989) The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern, Med. 149, 1514-1520.
7. Kasai H., Okada Y., Kashiwabara T., Ogawa N., Izawa T. and Fukushima H. (1995) Differences between the effects of KRN4884, a novel potassium channel opener, and nifedipine on phenylephrine-induced responses in rat aorta. Jpn. J. Pharmac. 67(Suppl 1), 176pp.
8. Kashiwabara T., Okawara H., Nakajima T., Nakajima S., Murakami I., Yonezawa Y., Okada Y., Ogawa N., Izawa T. and Fukushima H. (1994) Vasodilating and antihypertensive properties of KRN4884, a novel long lasting potassium channel opener. Can. J. Physiol. Pharmac. 72(Suppl 1), 126pp.
9. Matzno S., Gohda M., Eda M., Ebisu H., Uno S., Ishida N., Nakamura N. and Yamanouchi K. (1994) A possible mechanism of action of a new potassium channel opener, AL0671, on lipid metabolism in obese Zucker rats. J. Pharmac. Exp. Ther. 271, 1666-1671.
10. Nakajima T., Nakajima S., Izawa T., Kashiwabara T. and Munezuka Y. (1994) Cyanoamidines II: synthesis and pharmacological activity of N-arylalkyl-N′-cyano-3-pyridinecarboxamidine. Chem. Pharm. Bull. 42, 2483-2490.
11. Nilsson-Ehle P., Garfinkel A. S. and Schotz M. C. (1980) Lipolytic enzyme and plasma lipoprotein metabolism. Ann. Rev. Biochem. 49, 667-693.
12. Olivier P., Plancke M. O., Theret N., Marzin D., Clavey V. and Fruchart J. C. (1988) Effects of fenofibrate on lipid metabolism and fatty acid distribution in Zucker rats. Atherosclerosis 74, 15-21.
13. Poyser R. H. and Hamilton T. C. (1994) Potassium channel modulators: current situation and future expectations. Drugs Future 19, 39-47.
14. + channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats. J. Pharmac. Exp. Ther. 258, 216-222.
15. Reaven G. M. (1988) Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37, 1595-1607.
16. Rockhold F. W., Goldenberg M. R. and Thompson W. L. (1989) Beneficial effects of pinacidil on blood lipids: comparison with prazosin and placebo in patients with hypertension. J. Lab. Clin. Med. 114, 646-654.
17. Sato A., Watanabe K., Fukuzumi H., Hase K., Ishida F. and Kamei T. (1991) Effect of simvastatin (MK-733) on plasma triacylglycerol levels in rats. Biochem. Pharmac. 41, 1163-1172.
18. Sugo I., Yoshida S., Satoh K., Kamei K., Imagawa J., Akima M., Nabata H., Hayasaka A. and Chiba N. (1994) Effects of KC-515, a new K channel opener, in several hypertensive and hyperlipidemia models of rats. Jpn. J. Pharmac. 64, 336pp.
19. Yanagisawa T. and Okada Y. (1993) The structure-activity relationship of KRN2391 as an N-K hybrid. Cardiovasc. Drug Rev. 11, 94-115.